|
HS Code |
258663 |
| Chemical Name | L-Ornithine L-Aspartate |
| Molecular Formula | C9H19N3O6 |
| Molecular Weight | 265.27 g/mol |
| Appearance | White crystalline powder |
| Solubility In Water | Freely soluble |
| Uses | Hepatic encephalopathy treatment |
| Route Of Administration | Oral or intravenous |
| Cas Number | 3230-94-2 |
| Storage Conditions | Store below 25°C, protected from light and moisture |
| Mechanism Of Action | Enhances urea cycle to reduce ammonia levels |
As an accredited L-Ornithine L-Aspartate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a white, sealed plastic bottle containing 100 grams of L-Ornithine L-Aspartate powder, labeled with dosage instructions and batch number. |
| Shipping | L-Ornithine L-Aspartate is shipped in tightly sealed, clearly labeled containers to protect against moisture and contamination. It should be transported under cool, dry conditions, away from direct sunlight and incompatible substances. Shipping documentation must comply with relevant regulations for safe handling and transportation of chemicals. |
| Storage | L-Ornithine L-Aspartate should be stored in a tightly closed container, protected from moisture and direct sunlight. Keep it in a cool, dry, and well-ventilated area, ideally at room temperature (15–25°C). Avoid exposure to excessive heat and sources of ignition. Always follow local and manufacturer guidelines for safe storage to prevent contamination and maintain product integrity. |
|
Purity 98%: L-Ornithine L-Aspartate with a purity of 98% is used in hepatic encephalopathy management, where it effectively reduces blood ammonia levels. Molecular Weight 266.25 g/mol: L-Ornithine L-Aspartate with a molecular weight of 266.25 g/mol is used in clinical formulations, where it ensures consistent pharmacokinetics and therapeutic delivery. pH Stability 4.0-7.0: L-Ornithine L-Aspartate stable in the pH range of 4.0-7.0 is applied in intravenous solutions, where it maintains chemical integrity during administration. Water Solubility >100 g/L: L-Ornithine L-Aspartate with water solubility greater than 100 g/L is used in oral and injectable therapies, where it promotes rapid absorption and bioavailability. Particle Size <150 μm: L-Ornithine L-Aspartate with a particle size below 150 micrometers is utilized in tablet formulation, where it improves compressibility and uniform dosage distribution. Melting Point 226-230°C: L-Ornithine L-Aspartate with a melting point of 226-230°C is used in solid-state storage, where it ensures stability under standard pharmaceutical processing conditions. Heavy Metals Content <10 ppm: L-Ornithine L-Aspartate with heavy metals content below 10 ppm is employed in parenteral preparations, where it guarantees patient safety and regulatory compliance. Stability Temperature up to 40°C: L-Ornithine L-Aspartate with stability up to 40°C is used in global shipping, where it preserves efficacy during transport and storage in warm climates. |
Competitive L-Ornithine L-Aspartate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
At our facility, we focus on one core principle: quality begins at the source. Our L-Ornithine L-Aspartate doesn't come from an anonymous supply chain. We design, produce, and package this compound within our own walls, using methods that have evolved from years working with amino acid chemistry. Every batch that leaves our plant reflects the same standards, whether it is destined for clinical use, laboratory research, or specialized nutrition applications.
L-Ornithine L-Aspartate stands out among amino acid salts for its ability to support ammonia reduction and hepatic health. From our perspective on the floor—where you watch processes every day—these features aren't just textbook facts. The feedback reaching us from partners and researchers forms a real-world loop between the lab and production line. This compound draws regular requests for its action in removing ammonia from blood, especially for individuals under hepatic stress. We’ve seen customers, ranging from transplant centers to metabolic disease labs, repeatedly emphasize the importance of reliable purity and defined characteristics.
We manufacture L-Ornithine L-Aspartate by reacting ornithine and aspartic acid under strictly monitored conditions. Our team closely tracks each batch throughout the synthesis, ensuring full conversion while avoiding contamination. As a result, the final product contains consistent ratios of its constituent amino acids and reaches purity levels above 99%, determined by HPLC. Because most concerns point toward product consistency and traceability, each batch is accompanied by comprehensive spectroscopic and chromatographic profiles.
We offer this compound as a fine, free-flowing white powder. The particle size range averages 120-220 microns, based on real-time laser particle measurement; content analyses fall within a narrow margin. We maintain moisture levels below 0.5%, confirmed by Karl Fischer titration, to guard against clumping or degradation during storage. Packaging options start at 1 kg, scaling up to 25 kg drums for institutional demand. Whether scientists request small-scale pouches for trial runs or large orders for commercial preparations, we control every step—grinding, sifting, packaging, and sealing—inside a controlled atmosphere facility.
From a manufacturer’s post, consistency stems from routine handling—the way our staff measure feedstocks, clean vessels, and test in-process samples every shift. We have learned not to trust just theoretical recipes. Amino acid salts, including L-Ornithine L-Aspartate, can be sensitive to humidity, exposure, and even pressure changes during transfer. Over time, we have installed enclosed conveying systems and in-line moisture monitoring, since we know an apparently minor batch shift can lead to customer complaints or even compromised research outcomes. These steps have helped us retain clients whose own products demand predictable performance.
Doctors and scientists in hepatology rely on L-Ornithine L-Aspartate as part of their approach to managing hepatic encephalopathy. The compound is valued for supporting ammonia clearance, and the mechanism—facilitating the urea cycle and glutamine synthesis—is well-supported by clinical data. On the production line, every inquiry adds to our understanding of real need. Pharmaceutical firms ask about compatibility in intravenous formulations. Nutrition companies check flow characteristics and solubility. Researchers may request super-fine grades for tissue culture applications. Over the years, such conversations drive our focus on batch traceability and physical quality.
A lot of shortcuts exist in the amino acid industry. We source raw ornithine and aspartic acid with full documentation, but we work further: Every incoming lot goes through in-house FTIR spectroscopy and microbiological testing for total plate count, yeast, mold, and pathogens. No batch enters synthesis if it doesn’t meet our baseline, whether for amino acid profile or heavy metal content. For us, these habits go back to the early days, when one contaminated shipment could stall an entire season’s output. Our staff—some here across generations—know the pitfalls of approving a questionable batch.
Our workflow always includes multiple filtrations, followed by vacuum drying at controlled temperatures. We strictly limit heat to preserve amino group integrity and prevent racemization. The crew checks analytic samples after every step. Though such effort may look obsessive, this vigilance is no luxury—the market for L-Ornithine L-Aspartate depends on trust. One report of off-odors or discoloration can turn buyers away for good. We often consult with formulation teams on end-use study data, and we react quickly if pigmented or degraded lots show up, rooting out the source before it affects a full shipment.
As producers, we often get asked what sets L-Ornithine L-Aspartate apart from blends of its component amino acids or similar compounds like L-Ornithine hydrochloride. The answer lies in the dual functionality and stability when both ornithine and aspartic acid are tightly bound in a crystalline salt. This results in better solubility and compatibility in aqueous solutions, which matters for injectable or high-precision formulations needed in clinical settings. We have run solubility and dissolution rate comparisons in-house; L-Ornithine L-Aspartate reliably passes quality thresholds, while simple mixtures can separate, form clusters, or alter pH.
Our customers in research sometimes request pure L-ornithine or L-aspartic acid, but most pharmaceutical clients specifically order L-Ornithine L-Aspartate for its performance in metabolic processes. The molecular structure also enables more predictable pharmacokinetics in animal models. The aspartate anion does more than balance charge: It participates in detoxification and transmission cycles that doctors monitor bloodwork for. Over years supplying both bulk amino acids and this specific salt, the number of questions about stability, blend limitations, or residue has steadily fallen for users choosing the direct salt form over blends.
Other manufacturers might sell blends or alternate salts, yet not all reach tight controls for moisture, contaminants, and particle size. Our own investment in isolation and finishing equipment lets us testify to consistent outcomes—granulation tests, loss on drying, and impurity readings approach reference standards batch after batch. This product delivers clear, stable solutions when dissolved, and our analytical staff tracks batch deviation to avoid customer surprises.
Complying with internationally accepted good manufacturing practices never stops at paperwork. We operate under continuous internal audits and prepare for third-party inspections. Our plant’s documentation includes process descriptions, in-process control charts, and every analytic record—for at least ten years per batch. Demand for L-Ornithine L-Aspartate often comes with requests for certificates proving GMP adherence, allergen assessments, and residue declarations. Over time, this has given us a clear view of where customers lose trust in more loosely-regulated sources. We actively participate in batch recalls and customer investigations, whenever necessary, to trace issues down to the gram.
Production of L-Ornithine L-Aspartate remains sensitive to minor process upticks—slight shifts in pH, errant batch temperatures, or residual feedstock contamination can introduce unwanted byproducts. We install sensors to pick up such events before they cause loss, sometimes scrapping whole intermediate lots to maintain downstream integrity. During seasonal humidity spikes, we run extra sweeps and extend pre-drying times, since staff watch caking or stickiness form in even slightly damp material and halt the process then and there.
Our team holds weekly meetings to review customer feedback, which sometimes includes comments on packaging or handling at the last mile. Changes in packing geometry, bag thickness, or box stacking all affect shelf life for L-Ornithine L-Aspartate. Staff keep an eye on trends, adjusting protocols as needed. Regular training sets expectations for handoff between shifts, ensuring no batch sits in an intermediate state longer than necessary, avoiding issues that show up only after weeks in a buyer’s facility.
Traceability is more than a checklist. Every package of L-Ornithine L-Aspartate from our plant carries a lot number tying back to syntheses, cleanroom logs, raw material batches, testing data, and shipment details. We have adopted electronic systems allowing partners to access certificate-of-analysis information and quality control documents for every shipment, increasing transparency while answering regulatory and end-user questions in hours, not days. From our front office to the last person reviewing shipping labels, this effort reduces confusion—and the frequency of customer audits has dropped as a result.
As a manufacturer handling sensitive amino acids, worker safety and environmental responsibility come standard in our process. Most staff here have completed specific training on chemical hygiene, safe handling, and waste segregation. We recapture and recycle process water; ammonia and acidic vapors from production receive neutralization. Since aspartic acid and ornithine are both derived from natural sources, we partner closely with suppliers to verify not just composition, but absence of hazardous residues or contaminants carried over from extraction or fermentation. Over time, this has led us to favor suppliers who provide full traceability, so we prevent introducing unintended pollutants into the final L-Ornithine L-Aspartate product.
Most process adjustments come out of experience, not just management meetings. When a new lot of aspartic acid showed slightly different melting points on our QC tests, shop floor staff discovered a change in the upstream enzymatic hydrolysis used by our supplier. We worked together—operators, chemists, and procurement—to adjust both our criteria and feeding schedules so the next batch performed as expected. Rarely does an external auditor spot changes faster than hands-on crew in the drying room, so most process improvements begin at the ground level.
Each time customers report back, especially those in the field or clinic, we analyze recurring themes, sometimes feeding unexpected use-case reports or quality comments into our next review cycle. This habit—maintained across decades—means both major and minor defects show up less frequently. Reliable L-Ornithine L-Aspartate becomes not a laboratory abstraction, but a true input for medicine or research. When a new customer switches from a blend or from less-controlled origins, the improvement speaks through clearer solutions, more accurate dosing, and less routine troubleshooting.
Demand for L-Ornithine L-Aspartate crosses boundaries between clinical, research, and industrial uses. We supply major pharmaceutical partners formulating the compound into intravenous and oral treatments for hepatic encephalopathy. Clinical feedback reminds us that solubility and absence of visible particles carry more weight than price for their applications. Research partners give us ongoing feedback about reproducibility and how even minor changes in powder characteristics can derail experiments or yield inconsistent metabolic outcomes.
Nutrition companies and dietary supplement makers show concern for flowability during mixing and encapsulation. Our efforts to maintain tight particle size distribution and moisture content answer directly to their pressure points—batch after batch, the stories repeat: better capsule fill rates, no need for anti-caking agents, more stable shelf storage. Our investment in equipment comes from hearing, over and over, how packaging or inconsistency disrupts end-user trust. These partners watch every test result and demand open answers if specifications drift.
Building a reputation for L-Ornithine L-Aspartate requires meeting not just written standards, but those unwritten cues relayed from end-users. Most bulk buyers check routine documentation—assay, heavy metals, residual solvents, microbial load. They often call back weeks later, recounting downstream performance: complaints over graininess vanish, clear solutions persist, even clinical outcomes track as expected. That trust cements ongoing relationships. We say this from direct calls and visits to partner sites—on those occasions where a product meets resistance during final formulation, we trace it back, batch by batch, cause by cause, until both sides find the answer.
Comparisons with other related products don’t stop at chemical structure. L-Ornithine L-Aspartate simply handles better: it dissolves rapidly, resists caking, and lets users scale from flask to production tank. Other compounds or blends may suit basic research, but for critical care and precision dosing, no shortcut matches the salt’s documented performance.
Our ongoing work involves more than delivering a stock item. We continue to review advances in analytical chemistry, investing in more sensitive impurity detection. Every supplier gets regular site visits from our procurement staff. Newer production lines rely on closed-system transfer and real-time monitoring, further cutting down cross-contamination and airborne introduction of foreign matter. Our long-term relationship with users of L-Ornithine L-Aspartate stems directly from this ongoing vigilance.
While industry shifts between suppliers or trends toward cheaper alternatives, we stay in touch with core scientific needs: measurable purity, repeat performance, straightforward documentation. Our investment returns each time a user reports improved handling, fewer out-of-spec failures, or more consistent results in clinical application. Each process change or improvement gets documented—not as a formality, but as a roadmap for the next generation of staff learning the ropes.
Manufacturers carry a unique perspective—each gram of L-Ornithine L-Aspartate reflects dozens of real-world improvements. Not every change comes from regulatory demand; many originate from hours spent watching a batch crystallize, responding to rejected shipments, or learning from skilled staff on the floor. This knowledge accumulates, turning a chemical product from a commodity into a trusted tool. Labs and hospitals might only see the sealed container; for us, every container ties back to a history of attention, problem-solving, and close contact with the needs of science and medicine.
Our work doesn’t end at the loading dock. Feedback from every shipment, every returned drum, every technical inquiry cycles back to our daily routines. We fix what we can, trace problems, and act before issues grow. L-Ornithine L-Aspartate is more than just a chemical to us—it’s the result of careful, evolving collaboration, always pushing toward reliability, safety, and traceable quality.
Years producing L-Ornithine L-Aspartate reveal this much: chemical formulas alone never guarantee performance. Only steady work—tight production control, active problem-solving, and consistent dialogue with users—delivers the kind of batch integrity and reliability that clinicians, researchers, and manufacturers truly expect. Rather than rest on a label or certification, our staff keep reviewing, testing, and adjusting, listening to every partner along the line. For us, this product represents not just output, but commitment to a transparent, scientifically anchored process, carried out by people whose expertise and habits shape every shipment we deliver.